Stock market quotes, forex, financial news, forex tools – money-investing.com

Gilead Sciences soars by 13%

 Breaking News
  • Boeing announced the start of massive layoffs The Boeing Company has no choice but to take drastic measures. The world’s largest manufacturer of space and aviation equipment is forced to reduce the number of staff by 13...
  • Serious drawdown of oil quotes Today, oil is actively declining. A very significant increase in the reserves of “black gold” in the United States caused this drop. Moreover, the fears that Russia will not reduce...
  • Swiss watch makers are in crisis Swiss watch exports in April crashed at a record pace the drop has totaled 81% compared with the same period last year. Halting production and difficulties with sales caused by...
  • The intensification of the conflict between the USA and China leads to reduction of oil prices The energy market has started the trading session rather unsuccessfully. The next round of the trade war between the States and China caused the price fall. Because of this investors...
  • Germany saves Lufthansa An air carrier Deutsche Lufthansa AG has suffered losses because of the spread of the coronavirus pandemic. It became known that the German government had not left the matter unattended...
Gilead Sciences soars by 13%
April 17
13:00 2020

Today, investors have had an opportunity to see an unprecedented rise in shares of the American company Gilead Sciences Inc. A biopharmaceutical company has been recently engaged in creation of a cure for coronavirus. It seems that it is their specialists who will be able to be the first to combat the virus. An experimental drug developed by the company is called remdesivir. Clinical trials are being held at the University of Chicago Medical Center. It became known that most of the patients in serious condition, sometimes after taking the medicine had been released from hospital. This is a fairly impressive control group, the total number of which is 125 people.

Gilead Sciences specialists are currently conducting mass drug tests on patients whose condition is assessed as grave and moderate. The company’s goal is to test four thousand patients.

Once the impressive successes of the biopharmaceuticals became known to the public, the stock of Gilead Sciences began to grow. Today, the growth continues; since the beginning of the session, the shares have increased 13%.

 

The material was prepared with the participation of Katya Wilson,
a leading analyst of the brokerage company
UFT Group

Related Articles

0 Comments

No Comments Yet!

There are no comments at the moment, do you want to add one?

Write a comment

Write a Comment